<scp>ILC</scp>2 frequency and activity are inhibited by glucocorticoid treatment via <scp>STAT</scp> pathway in patients with asthma

Abstract

The data suggested that glucocorticoid administration could be effective in treating asthma by regulating ILC2s via MEK/JAK-STAT signalling pathways. This provides a new understanding of glucocorticoid application in regard to allergic diseases.